Eventually, the committee reduced its demand to focus on documents involving decision-making after the administration shut down the Fast and Furious program.
"We're still looking through the data and making a decision about how, when, and whether to continue with the program, " says Daniel Bloomfield, senior director of cardiology at Merck.